Report Detail

Medical Devices & Consumables COVID-19 Impact on Global Radiopharmaceuticals in Nuclear Medical, Market Insights and Forecast to 2026

  • RnM4082068
  • |
  • 29 June, 2020
  • |
  • Global
  • |
  • 148 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

1 Study Coverage

  • 1.1 Radiopharmaceuticals in Nuclear Medical Product Introduction
  • 1.2 Key Market Segments in This Study
  • 1.3 Key Manufacturers Covered: Ranking of Global Top Radiopharmaceuticals in Nuclear Medical Manufacturers by Revenue in 2019
  • 1.4 Market by Type
    • 1.4.1 Global Radiopharmaceuticals in Nuclear Medical Market Size Growth Rate by Type
    • 1.4.2 Diagnostic Radiopharmaceuticals
    • 1.4.3 Therapy Radiopharmaceuticals
    • 1.4.4 Enriched Stable Isotopes
  • 1.5 Market by Application
    • 1.5.1 Global Radiopharmaceuticals in Nuclear Medical Market Size Growth Rate by Application
    • 1.5.2 Diagnostic Application
    • 1.5.3 Therapeutic Application
    • 1.5.4 Research
    • 1.5.5 Pharmaceutical
    • 1.5.6 Industrial
  • 1.6 Coronavirus Disease 2019 (Covid-19): Radiopharmaceuticals in Nuclear Medical Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Radiopharmaceuticals in Nuclear Medical Industry
      • 1.6.1.1 Radiopharmaceuticals in Nuclear Medical Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Radiopharmaceuticals in Nuclear Medical Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Radiopharmaceuticals in Nuclear Medical Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Radiopharmaceuticals in Nuclear Medical Market Size Estimates and Forecasts
    • 2.1.1 Global Radiopharmaceuticals in Nuclear Medical Revenue Estimates and Forecasts 2015-2026
    • 2.1.2 Global Radiopharmaceuticals in Nuclear Medical Production Capacity Estimates and Forecasts 2015-2026
    • 2.1.3 Global Radiopharmaceuticals in Nuclear Medical Production Estimates and Forecasts 2015-2026
  • 2.2 Global Radiopharmaceuticals in Nuclear Medical Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Analysis of Competitive Landscape
    • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 2.3.2 Global Radiopharmaceuticals in Nuclear Medical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.3.3 Global Radiopharmaceuticals in Nuclear Medical Manufacturers Geographical Distribution
  • 2.4 Key Trends for Radiopharmaceuticals in Nuclear Medical Markets & Products
  • 2.5 Primary Interviews with Key Radiopharmaceuticals in Nuclear Medical Players (Opinion Leaders)

3 Market Size by Manufacturers

  • 3.1 Global Top Radiopharmaceuticals in Nuclear Medical Manufacturers by Production Capacity
    • 3.1.1 Global Top Radiopharmaceuticals in Nuclear Medical Manufacturers by Production Capacity (2015-2020)
    • 3.1.2 Global Top Radiopharmaceuticals in Nuclear Medical Manufacturers by Production (2015-2020)
    • 3.1.3 Global Top Radiopharmaceuticals in Nuclear Medical Manufacturers Market Share by Production
  • 3.2 Global Top Radiopharmaceuticals in Nuclear Medical Manufacturers by Revenue
    • 3.2.1 Global Top Radiopharmaceuticals in Nuclear Medical Manufacturers by Revenue (2015-2020)
    • 3.2.2 Global Top Radiopharmaceuticals in Nuclear Medical Manufacturers Market Share by Revenue (2015-2020)
    • 3.2.3 Global Top 10 and Top 5 Companies by Radiopharmaceuticals in Nuclear Medical Revenue in 2019
  • 3.3 Global Radiopharmaceuticals in Nuclear Medical Price by Manufacturers
  • 3.4 Mergers & Acquisitions, Expansion Plans

4 Radiopharmaceuticals in Nuclear Medical Production by Regions

  • 4.1 Global Radiopharmaceuticals in Nuclear Medical Historic Market Facts & Figures by Regions
    • 4.1.1 Global Top Radiopharmaceuticals in Nuclear Medical Regions by Production (2015-2020)
    • 4.1.2 Global Top Radiopharmaceuticals in Nuclear Medical Regions by Revenue (2015-2020)
  • 4.2 North America
    • 4.2.1 North America Radiopharmaceuticals in Nuclear Medical Production (2015-2020)
    • 4.2.2 North America Radiopharmaceuticals in Nuclear Medical Revenue (2015-2020)
    • 4.2.3 Key Players in North America
    • 4.2.4 North America Radiopharmaceuticals in Nuclear Medical Import & Export (2015-2020)
  • 4.3 Europe
    • 4.3.1 Europe Radiopharmaceuticals in Nuclear Medical Production (2015-2020)
    • 4.3.2 Europe Radiopharmaceuticals in Nuclear Medical Revenue (2015-2020)
    • 4.3.3 Key Players in Europe
    • 4.3.4 Europe Radiopharmaceuticals in Nuclear Medical Import & Export (2015-2020)
  • 4.4 China
    • 4.4.1 China Radiopharmaceuticals in Nuclear Medical Production (2015-2020)
    • 4.4.2 China Radiopharmaceuticals in Nuclear Medical Revenue (2015-2020)
    • 4.4.3 Key Players in China
    • 4.4.4 China Radiopharmaceuticals in Nuclear Medical Import & Export (2015-2020)
  • 4.5 Japan
    • 4.5.1 Japan Radiopharmaceuticals in Nuclear Medical Production (2015-2020)
    • 4.5.2 Japan Radiopharmaceuticals in Nuclear Medical Revenue (2015-2020)
    • 4.5.3 Key Players in Japan
    • 4.5.4 Japan Radiopharmaceuticals in Nuclear Medical Import & Export (2015-2020)

5 Radiopharmaceuticals in Nuclear Medical Consumption by Region

  • 5.1 Global Top Radiopharmaceuticals in Nuclear Medical Regions by Consumption
    • 5.1.1 Global Top Radiopharmaceuticals in Nuclear Medical Regions by Consumption (2015-2020)
    • 5.1.2 Global Top Radiopharmaceuticals in Nuclear Medical Regions Market Share by Consumption (2015-2020)
  • 5.2 North America
    • 5.2.1 North America Radiopharmaceuticals in Nuclear Medical Consumption by Application
    • 5.2.2 North America Radiopharmaceuticals in Nuclear Medical Consumption by Countries
    • 5.2.3 U.S.
    • 5.2.4 Canada
  • 5.3 Europe
    • 5.3.1 Europe Radiopharmaceuticals in Nuclear Medical Consumption by Application
    • 5.3.2 Europe Radiopharmaceuticals in Nuclear Medical Consumption by Countries
    • 5.3.3 Germany
    • 5.3.4 France
    • 5.3.5 U.K.
    • 5.3.6 Italy
    • 5.3.7 Russia
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Radiopharmaceuticals in Nuclear Medical Consumption by Application
    • 5.4.2 Asia Pacific Radiopharmaceuticals in Nuclear Medical Consumption by Regions
    • 5.4.3 China
    • 5.4.4 Japan
    • 5.4.5 South Korea
    • 5.4.6 India
    • 5.4.7 Australia
    • 5.4.8 Taiwan
    • 5.4.9 Indonesia
    • 5.4.10 Thailand
    • 5.4.11 Malaysia
    • 5.4.12 Philippines
    • 5.4.13 Vietnam
  • 5.5 Central & South America
    • 5.5.1 Central & South America Radiopharmaceuticals in Nuclear Medical Consumption by Application
    • 5.5.2 Central & South America Radiopharmaceuticals in Nuclear Medical Consumption by Country
    • 5.5.3 Mexico
    • 5.5.3 Brazil
    • 5.5.3 Argentina
  • 5.6 Middle East and Africa
    • 5.6.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Consumption by Application
    • 5.6.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Consumption by Countries
    • 5.6.3 Turkey
    • 5.6.4 Saudi Arabia
    • 5.6.5 U.A.E

6 Market Size by Type (2015-2026)

  • 6.1 Global Radiopharmaceuticals in Nuclear Medical Market Size by Type (2015-2020)
    • 6.1.1 Global Radiopharmaceuticals in Nuclear Medical Production by Type (2015-2020)
    • 6.1.2 Global Radiopharmaceuticals in Nuclear Medical Revenue by Type (2015-2020)
    • 6.1.3 Radiopharmaceuticals in Nuclear Medical Price by Type (2015-2020)
  • 6.2 Global Radiopharmaceuticals in Nuclear Medical Market Forecast by Type (2021-2026)
    • 6.2.1 Global Radiopharmaceuticals in Nuclear Medical Production Forecast by Type (2021-2026)
    • 6.2.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Type (2021-2026)
    • 6.2.3 Global Radiopharmaceuticals in Nuclear Medical Price Forecast by Type (2021-2026)
  • 6.3 Global Radiopharmaceuticals in Nuclear Medical Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)

  • 7.2.1 Global Radiopharmaceuticals in Nuclear Medical Consumption Historic Breakdown by Application (2015-2020)
  • 7.2.2 Global Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Application (2021-2026)

8 Corporate Profiles

  • 8.1 Bracco Imaging
    • 8.1.1 Bracco Imaging Corporation Information
    • 8.1.2 Bracco Imaging Overview and Its Total Revenue
    • 8.1.3 Bracco Imaging Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.1.4 Bracco Imaging Product Description
    • 8.1.5 Bracco Imaging Recent Development
  • 8.2 Cambridge Isotope Laboratories
    • 8.2.1 Cambridge Isotope Laboratories Corporation Information
    • 8.2.2 Cambridge Isotope Laboratories Overview and Its Total Revenue
    • 8.2.3 Cambridge Isotope Laboratories Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.2.4 Cambridge Isotope Laboratories Product Description
    • 8.2.5 Cambridge Isotope Laboratories Recent Development
  • 8.3 Cardinal Health
    • 8.3.1 Cardinal Health Corporation Information
    • 8.3.2 Cardinal Health Overview and Its Total Revenue
    • 8.3.3 Cardinal Health Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.3.4 Cardinal Health Product Description
    • 8.3.5 Cardinal Health Recent Development
  • 8.4 Medtronic
    • 8.4.1 Medtronic Corporation Information
    • 8.4.2 Medtronic Overview and Its Total Revenue
    • 8.4.3 Medtronic Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.4.4 Medtronic Product Description
    • 8.4.5 Medtronic Recent Development
  • 8.5 Eczacibasi-Monrol
    • 8.5.1 Eczacibasi-Monrol Corporation Information
    • 8.5.2 Eczacibasi-Monrol Overview and Its Total Revenue
    • 8.5.3 Eczacibasi-Monrol Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.5.4 Eczacibasi-Monrol Product Description
    • 8.5.5 Eczacibasi-Monrol Recent Development
  • 8.6 Fujifilm Holdings Corporation
    • 8.6.1 Fujifilm Holdings Corporation Corporation Information
    • 8.6.2 Fujifilm Holdings Corporation Overview and Its Total Revenue
    • 8.6.3 Fujifilm Holdings Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.6.4 Fujifilm Holdings Corporation Product Description
    • 8.6.5 Fujifilm Holdings Corporation Recent Development
  • 8.7 GE Healthcare (Subsidiary Of General Electric Company)
    • 8.7.1 GE Healthcare (Subsidiary Of General Electric Company) Corporation Information
    • 8.7.2 GE Healthcare (Subsidiary Of General Electric Company) Overview and Its Total Revenue
    • 8.7.3 GE Healthcare (Subsidiary Of General Electric Company) Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.7.4 GE Healthcare (Subsidiary Of General Electric Company) Product Description
    • 8.7.5 GE Healthcare (Subsidiary Of General Electric Company) Recent Development
  • 8.8 IBA Group
    • 8.8.1 IBA Group Corporation Information
    • 8.8.2 IBA Group Overview and Its Total Revenue
    • 8.8.3 IBA Group Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.8.4 IBA Group Product Description
    • 8.8.5 IBA Group Recent Development
  • 8.9 Lantheus Medical Imaging
    • 8.9.1 Lantheus Medical Imaging Corporation Information
    • 8.9.2 Lantheus Medical Imaging Overview and Its Total Revenue
    • 8.9.3 Lantheus Medical Imaging Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.9.4 Lantheus Medical Imaging Product Description
    • 8.9.5 Lantheus Medical Imaging Recent Development
  • 8.10 Nordion
    • 8.10.1 Nordion Corporation Information
    • 8.10.2 Nordion Overview and Its Total Revenue
    • 8.10.3 Nordion Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.10.4 Nordion Product Description
    • 8.10.5 Nordion Recent Development
  • 8.11 Ntp Radioisotopes
    • 8.11.1 Ntp Radioisotopes Corporation Information
    • 8.11.2 Ntp Radioisotopes Overview and Its Total Revenue
    • 8.11.3 Ntp Radioisotopes Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.11.4 Ntp Radioisotopes Product Description
    • 8.11.5 Ntp Radioisotopes Recent Development
  • 8.12 Siemens Healthcare
    • 8.12.1 Siemens Healthcare Corporation Information
    • 8.12.2 Siemens Healthcare Overview and Its Total Revenue
    • 8.12.3 Siemens Healthcare Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.12.4 Siemens Healthcare Product Description
    • 8.12.5 Siemens Healthcare Recent Development
  • 8.13 Taiyo Nippon Sanso Corporation
    • 8.13.1 Taiyo Nippon Sanso Corporation Corporation Information
    • 8.13.2 Taiyo Nippon Sanso Corporation Overview and Its Total Revenue
    • 8.13.3 Taiyo Nippon Sanso Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.13.4 Taiyo Nippon Sanso Corporation Product Description
    • 8.13.5 Taiyo Nippon Sanso Corporation Recent Development
  • 8.14 Urenco Limited
    • 8.14.1 Urenco Limited Corporation Information
    • 8.14.2 Urenco Limited Overview and Its Total Revenue
    • 8.14.3 Urenco Limited Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.14.4 Urenco Limited Product Description
    • 8.14.5 Urenco Limited Recent Development
  • 8.15 Rotem Industries
    • 8.15.1 Rotem Industries Corporation Information
    • 8.15.2 Rotem Industries Overview and Its Total Revenue
    • 8.15.3 Rotem Industries Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.15.4 Rotem Industries Product Description
    • 8.15.5 Rotem Industries Recent Development

9 Production Forecasts by Regions

  • 9.1 Global Top Radiopharmaceuticals in Nuclear Medical Regions Forecast by Revenue (2021-2026)
  • 9.2 Global Top Radiopharmaceuticals in Nuclear Medical Regions Forecast by Production (2021-2026)
  • 9.3 Key Radiopharmaceuticals in Nuclear Medical Production Regions Forecast
    • 9.3.1 North America
    • 9.3.2 Europe
    • 9.3.3 China
    • 9.3.4 Japan

10 Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Region

  • 10.1 Global Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Region (2021-2026)
  • 10.2 North America Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Region (2021-2026)
  • 10.3 Europe Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Region (2021-2026)
  • 10.4 Asia Pacific Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Region (2021-2026)
  • 10.5 Latin America Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Region (2021-2026)
  • 10.6 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis

  • 11.1 Value Chain Analysis
  • 11.2 Sales Channels Analysis
    • 11.2.1 Radiopharmaceuticals in Nuclear Medical Sales Channels
    • 11.2.2 Radiopharmaceuticals in Nuclear Medical Distributors
  • 11.3 Radiopharmaceuticals in Nuclear Medical Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

  • 12.1 Market Opportunities and Drivers
  • 12.2 Market Challenges
  • 12.3 Market Risks/Restraints
  • 12.4 Porter's Five Forces Analysis

13 Key Finding in The Global Radiopharmaceuticals in Nuclear Medical Study

    14 Appendix

    • 14.1 Research Methodology
      • 14.1.1 Methodology/Research Approach
      • 14.1.2 Data Source
    • 14.2 Author Details

    Radiopharmaceuticals in Nuclear Medical market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Radiopharmaceuticals in Nuclear Medical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Radiopharmaceuticals in Nuclear Medical market is segmented into
    Diagnostic Radiopharmaceuticals
    Therapy Radiopharmaceuticals
    Enriched Stable Isotopes

    Segment by Application, the Radiopharmaceuticals in Nuclear Medical market is segmented into
    Diagnostic Application
    Therapeutic Application
    Research
    Pharmaceutical
    Industrial

    Regional and Country-level Analysis
    The Radiopharmaceuticals in Nuclear Medical market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Radiopharmaceuticals in Nuclear Medical market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
    Competitive Landscape and Radiopharmaceuticals in Nuclear Medical Market Share Analysis

    Radiopharmaceuticals in Nuclear Medical market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Radiopharmaceuticals in Nuclear Medical by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Radiopharmaceuticals in Nuclear Medical business, the date to enter into the Radiopharmaceuticals in Nuclear Medical market, Radiopharmaceuticals in Nuclear Medical product introduction, recent developments, etc.
    The major vendors covered:
    Bracco Imaging
    Cambridge Isotope Laboratories
    Cardinal Health
    Medtronic
    Eczacibasi-Monrol
    Fujifilm Holdings Corporation
    GE Healthcare (Subsidiary Of General Electric Company)
    IBA Group
    Lantheus Medical Imaging
    Nordion
    Ntp Radioisotopes
    Siemens Healthcare
    Taiyo Nippon Sanso Corporation
    Urenco Limited


    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Radiopharmaceuticals in Nuclear Medical. Industry analysis & Market Report on COVID-19 Impact on Global Radiopharmaceuticals in Nuclear Medical is a syndicated market report, published as COVID-19 Impact on Global Radiopharmaceuticals in Nuclear Medical, Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Radiopharmaceuticals in Nuclear Medical market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,900.00
    $7,350.00
    $9,800.00
    3,889.93
    5,834.89
    7,779.86
    4,324.55
    6,486.82
    8,649.10
    524,986.00
    787,479.00
    1,049,972.00
    368,442.76
    552,664.14
    736,885.52
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report